Li Qian, Rempel Julia D, Yang Jiaqi, Minuk Gerald Y
Section of Hepatology, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
J Clin Exp Hepatol. 2022 May-Jun;12(3):808-817. doi: 10.1016/j.jceh.2021.11.011. Epub 2021 Nov 25.
Innate immune responses to gut-derived pathogen-associated molecular patterns (PAMPs) have been implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Whether NAFLD patients have increased sensitivity to PAMP exposure has yet to be reported.
Peripheral blood mononuclear cell (PBMC)/monocytes were exposed to lipopolysaccharide (LPS), Pam3CSK4, or BSA conjugated palmitate . Changes in toll-like receptors (TLR), cytokines, and chemokine receptors (CR) expressions were documented by flow cytometry and/or enzyme-linked immunoabsorbent assays (ELISAs).
TLR2 and TLR4 expression were similar at baseline and increased to a similar extent (TLR2) or remained unchanged (TLR4) following PAMP exposure in NAFLD and healthy control (HC) monocytes. Proinflammatory IL-1β and IL-6 levels were similar at baseline but increased in a concentration-dependent manner to a greater extent in NAFLD PBMCs. CCR1 and CCR2 expressions at baseline were similar and decreased to a similar extent in NAFLD and HC monocytes. The extent of PAMP-induced proinflammatory cytokine release correlated with evidence of hepatocyte injury (CK18M30 levels).
NAFLD patients have increased proinflammatory cytokine responses following exposure to PAMPs relative to HC subjects. This response is concentration-dependent and correlates with the extent of hepatic injury.
对肠道来源的病原体相关分子模式(PAMPs)的先天性免疫反应与非酒精性脂肪性肝病(NAFLD)的发病机制有关。NAFLD患者对PAMP暴露的敏感性是否增加尚未见报道。
将外周血单核细胞(PBMC)/单核细胞暴露于脂多糖(LPS)、Pam3CSK4或牛血清白蛋白偶联棕榈酸酯。通过流式细胞术和/或酶联免疫吸附测定(ELISA)记录Toll样受体(TLR)、细胞因子和趋化因子受体(CR)表达的变化。
在NAFLD和健康对照(HC)单核细胞中,TLR2和TLR4表达在基线时相似,在PAMP暴露后,TLR2表达以相似程度增加(TLR4)或保持不变(TLR4)。促炎细胞因子IL-1β和IL-6水平在基线时相似,但在NAFLD PBMC中以浓度依赖性方式更大程度地增加。CCR1和CCR2在基线时的表达相似,在NAFLD和HC单核细胞中以相似程度降低。PAMP诱导的促炎细胞因子释放程度与肝细胞损伤证据(CK18M30水平)相关。
与HC受试者相比,NAFLD患者在暴露于PAMPs后促炎细胞因子反应增加。这种反应是浓度依赖性的,并且与肝损伤程度相关。